Purchase Order 75D30121P12710
Award Date
9/13/21
Potential Completion Date
9/2/22
Potential Value
$808K
Federal Agency
CDC Pittsburgh
Awardee
The Broad Institute, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cambridge, MA 02142, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $2,226,582.00 firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Broad Institute, Inc., doing business as Broad Institute of MIT and Harvard. The contract is for FY22 BAA TOPIC 7 and has a completion date of March 25, 2025. The Broad Institute is a non-profit biomedical and genomic research organization that frequently partners with government agencies like the NIH, CDC, DoD, and NSF to provide specialized scientific services...
The Broad Institute, Inc. was awarded a $4.4 million definitive cost-no-fee contract by the Centers for Disease Control and Prevention to support applied research addressing the continued public health emergency posed by COVID-19. Under the contract, the Broad Institute will sequence SARS-CoV-2 virus samples and conduct epidemiological analysis in collaboration with two major subcontractors, the Massachusetts General Hospital and the University of Massachusetts Medical School. The subcontractors...
The Centers for Disease Control and Prevention awarded a $4,600,633 definitive cost-no-fee contract to The Broad Institute, Inc. to demonstrate pan-pathogen and pathogen-agnostic genomic surveillance of clinical respiratory disease. As a non-profit research organization, The Broad Institute will leverage its expertise in large-scale genomic and health data analysis, integration and management to support the CDC's infectious disease initiatives. No set-aside designation was used for this award...
This contract is for research and development services awarded by the Centers for Disease Control and Prevention (CDC) to The Broad Institute, Inc., doing business as Broad Institute of MIT and Harvard. The contract has a ceiling value of $1,029,999.88 and a completion date of September 29, 2026. It is a definitive contract with a cost-no-fee pricing type, and there is no set-aside designation. The Broad Institute is a non-profit biomedical and genomic research organization that frequently...
<p>The Centers for Disease Control and Prevention awarded a $3.7 million definitive cost-no-fee contract to The Broad Institute, Inc., doing business as Broad Institute of MIT and Harvard, to advance CRISPR-based diagnostics in response to ongoing pathogenic threats under Broad Agency Announcement topic 20.1. The place of performance will be Cambridge, Massachusetts and work is expected to be completed by January 31, 2024.</p>
This is a federal contract award valued at $394,227.01 to The Broad Institute, Inc., doing business as Broad Institute of MIT and Harvard, a non-profit biomedical and genomic research organization. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), for TAS::75 0885::TAS BIOMEDICAL (APPLIED/EXPLORATORY) services. The contract has no set-aside designation. The Broad Institute frequently partners...
This is a delivery order under a multi-year, multi-award Indefinite Delivery Contract (IDC) awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to the Broad Institute of MIT and Harvard. The $24,910,368.70 firm fixed-price task order is for the Broad Institute to provide genomics data generation, analysis, and management services in support of the NHLBI's Trans-Omics for Precision Medicine (TOPMed) initiative. This work will...
This federal contract award issued by the Food and Drug Administration (FDA) to The Broad Institute, Inc. (doing business as Broad Institute of MIT and Harvard) is for a project titled "Comprehensive Spatio-Temporal Map of Gene Expression During Lethal Ebola Virus Disease". The $3,246,237.39 definitive contract has a performance period ending on Sep 30, 2023. The contract supports regulatory science and innovation research and development, as described in the FDA's Broad Agency...
This firm fixed-price purchase order for $108,629.18 was awarded by the National Institute of Environmental Health Sciences, a civilian agency, to The Broad Institute, Inc. for whole exome sequencing services. The contract has no set-aside designation, reflecting The Broad Institute's competitive capabilities in advanced genomic research and data analysis services. The Broad Institute has performed similar work for other federal agencies like the Centers for Disease Control and Prevention,...
This federal contract award was issued by the National Heart, Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to The Broad Institute, Inc., doing business as Broad Institute of MIT and Harvard. The $2,343,147.64 firm fixed price contract is a delivery order under the Centralized Omic REsource for TOPMed (CORE) indefinite delivery vehicle (IDV), which has a $500 million ceiling to support the Trans-Omics for Precision Medicine initiative through genomics data...